Drug application
HALOBETASOL PROPIONATE AND TAZAROTENE (HALOBETASOL PROPIONATE, TAZAROTENE)
Drugs@FDA ANDA 217190 · SUN PHARMA CANADA
Key facts
| Drug name | HALOBETASOL PROPIONATE AND TAZAROTENE |
|---|---|
| Active ingredients | HALOBETASOL PROPIONATE, TAZAROTENE |
| Application type | ANDA |
| Application number | 217190 |
| Company | SUN PHARMA CANADA |
| Dosage forms | LOTION, TOPICAL |
| Strength | 0.01%;0.045% |
| Marketing status | Prescription |
| TE codes | AB |
| Reference listed drug | No |
| Latest submission status date | May 2, 2025 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 1–9 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.